INTENSITY THERAPEUTICS, INC.

INTS · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.0B · 7 employees
88
SEC Filings
$4.2
Close 2026-08-05
7
Employees

Business Summary

OVERVIEW Intensity Therapeutics, Inc. is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction leading to anti-cancer immune activation. Our new approach involves the direct injection into tumors of a unique product created from our DfuseRx SM discovery platform. Intratumoral (IT) treatment, or treatment designed to contain a drug inside a tumor without spreading to the rest of the body, has been an objecti...

Latest Stock Quote

INTS 2026-08-05 $4.2 O:$4 H:$4.325 L:$3.995 Vol:0.1M VWAP:$4.1545
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-09

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-272025-12-310001567264-26-000024EDGAR88K words
2025-03-132024-12-310001567264-25-000010EDGAR—
2024-03-142023-12-310001628280-24-011207EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001567264-25-000103EDGAR16K words
2025-08-072025-06-300001567264-25-000077EDGAR—
2025-05-132025-03-310001567264-25-000039EDGAR—
2024-11-132024-09-300001567264-24-000052EDGAR—
2024-08-082024-06-300001567264-24-000041EDGAR—
2024-05-092024-03-310001567264-24-000010EDGAR—
2023-11-132023-09-300001213900-23-085791EDGAR—
2023-08-142023-06-300001213900-23-066740EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-270001567264-26-000025EDGAR3K words
2026-03-230001567264-26-000021EDGAR—
2026-03-060001567264-26-000014EDGAR—
2026-03-050001567264-26-000011EDGAR—
2026-02-130001567264-26-000007EDGAR—
2025-12-050001567264-25-000111EDGAR—
2025-12-040001567264-25-000109EDGAR—
2025-11-060001567264-25-000104EDGAR—
2025-10-310001628280-25-047855EDGAR—
2025-10-230001567264-25-000096EDGAR—

88 total filings indexed. 67 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Company Identity

CIK0001567264
TickerINTS
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.intensitytherapeutics.com
Listed2023-06-30

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 1482426dbdd2a8387a32c905e965835c7d4c9a233e64dc04b3b8e94448c1d485
parent: 722e108860e0abed881e055493d7ddb9bf8e5a405c88718bbc9fd0a694e935f4
content hash: 8e9fbb5db6c0847985d5649e993ac6eb9f2556fe7c60c90609578131c96db082
signed: 2026-08-10T19:03:47.764Z
sources: 11 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up INTS using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on INTS, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/INTS (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.